Chronic Myelomonocytic Leukemia, in Remission

2 clinical trials · Condition

Record	Firm	Date
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) (NCT06462365)	Tr1X, Inc.	2024-04-08
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397)	Roswell Park Cancer Institute	2017-08-09

Every clearance here is in the API, with alerts when new ones post.